APA

Press O. W., Unger J. M., Braziel R. M., Maloney D. G., Miller T. P., LeBlanc M., Gaynor E. R., Rivkin S. E. & Fisher R. I. (20031002). A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911. : Blood.

Chicago

Press Oliver W, Unger Joseph M, Braziel Rita M, Maloney David G, Miller Thomas P, LeBlanc Michael, Gaynor Ellen R, Rivkin Saul E and Fisher Richard I. 20031002. A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911. : Blood.

Harvard

Press O. W., Unger J. M., Braziel R. M., Maloney D. G., Miller T. P., LeBlanc M., Gaynor E. R., Rivkin S. E. and Fisher R. I. (20031002). A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911. : Blood.

MLA

Press Oliver W, Unger Joseph M, Braziel Rita M, Maloney David G, Miller Thomas P, LeBlanc Michael, Gaynor Ellen R, Rivkin Saul E and Fisher Richard I. A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911. : Blood. 20031002.